KIDS241220C25000
- 2.49
- +2.09+522.50%
OrthoPediatrics Newsroom
Top Premarket Gainers
Buy Rating for OrthoPediatrics Driven by Strong Financial Performance and Growth Potential
OrthoPediatrics Corp. to Participate in Upcoming Conferences
OrthoPediatrics Innovates in Pediatric Orthopedics Market
OrthoPediatrics Corp. (KIDS) Q3 2024 Earnings Call Transcript Summary
The Latest Analyst Ratings For OrthoPediatrics
Stifel Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $40
Q3 2024 OrthoPediatrics Corp Earnings Call
OrthoPediatrics | 10-Q: Q3 2024 Earnings Report
Needham Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $42
Truist Financial Maintains OrthoPediatrics(KIDS.US) With Hold Rating
Truist Financial Sticks to Their Hold Rating for OrthoPediatrics (KIDS)
JMP Securities Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $50
OrthoPediatrics: Strong Financial Performance and Growth Outlook Reinforce Buy Rating
Compared to Estimates, OrthoPediatrics (KIDS) Q3 Earnings: A Look at Key Metrics
OrthoPediatrics Boosts FY24 Revenue View to $202M- $204M,consensus $201.56M
OrthoPediatrics: Q3 Earnings Snapshot
OrthoPediatrics GAAP EPS of -$0.34 Misses by $0.08, Revenue of $54.57M Beats by $0.88M
Earnings Flash (KIDS) ORTHOPEDIATRICS Reports Q3 Revenue $54.6M
OrthoPediatrics | 8-K: OrthoPediatrics Corp. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance